190 related articles for article (PubMed ID: 15947088)
1. Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells.
Pan C; Nelson MS; Reyes M; Koodie L; Brazil JJ; Stephenson EJ; Zhao RC; Peters C; Selleck SB; Stringer SE; Gupta P
Blood; 2005 Sep; 106(6):1956-64. PubMed ID: 15947088
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.
Watson HA; Holley RJ; Langford-Smith KJ; Wilkinson FL; van Kuppevelt TH; Wynn RF; Wraith JE; Merry CL; Bigger BW
J Biol Chem; 2014 Dec; 289(52):36194-203. PubMed ID: 25359774
[TBL] [Abstract][Full Text] [Related]
3. Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity.
Khan SA; Nelson MS; Pan C; Gaffney PM; Gupta P
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1387-97. PubMed ID: 18385288
[TBL] [Abstract][Full Text] [Related]
4. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.
Allen BL; Filla MS; Rapraeger AC
J Cell Biol; 2001 Nov; 155(5):845-58. PubMed ID: 11724824
[TBL] [Abstract][Full Text] [Related]
5. The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.
Wu ZL; Zhang L; Yabe T; Kuberan B; Beeler DL; Love A; Rosenberg RD
J Biol Chem; 2003 May; 278(19):17121-9. PubMed ID: 12604602
[TBL] [Abstract][Full Text] [Related]
6. The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates.
Nurcombe V; Smart CE; Chipperfield H; Cool SM; Boilly B; Hondermarck H
J Biol Chem; 2000 Sep; 275(39):30009-18. PubMed ID: 10862617
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation.
Chipperfield H; Bedi KS; Cool SM; Nurcombe V
Int J Dev Biol; 2002; 46(4):661-70. PubMed ID: 12141455
[TBL] [Abstract][Full Text] [Related]
8. Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.
Hinek A; Wilson SE
Am J Pathol; 2000 Mar; 156(3):925-38. PubMed ID: 10702409
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2.
Jackson RA; Murali S; van Wijnen AJ; Stein GS; Nurcombe V; Cool SM
J Cell Physiol; 2007 Jan; 210(1):38-50. PubMed ID: 17051597
[TBL] [Abstract][Full Text] [Related]
10. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.
Ornitz DM; Herr AB; Nilsson M; Westman J; Svahn CM; Waksman G
Science; 1995 Apr; 268(5209):432-6. PubMed ID: 7536345
[TBL] [Abstract][Full Text] [Related]
11. Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells.
Johnson CE; Crawford BE; Stavridis M; Ten Dam G; Wat AL; Rushton G; Ward CM; Wilson V; van Kuppevelt TH; Esko JD; Smith A; Gallagher JT; Merry CL
Stem Cells; 2007 Aug; 25(8):1913-23. PubMed ID: 17464092
[TBL] [Abstract][Full Text] [Related]
12. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
13. Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Sakura N; Barrera L; Kida K; Kubota M; Orii T
J Inherit Metab Dis; 2010 Apr; 33(2):141-50. PubMed ID: 20162367
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fibroblast growth factor-2 activity by human ovarian cancer tumor endothelium.
Whitworth MK; Backen AC; Clamp AR; Wilson G; McVey R; Friedl A; Rapraeger AC; David G; McGown A; Slade RJ; Gallagher JT; Jayson GC
Clin Cancer Res; 2005 Jun; 11(12):4282-8. PubMed ID: 15958608
[TBL] [Abstract][Full Text] [Related]
15. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
Miao HQ; Ornitz DM; Aingorn E; Ben-Sasson SA; Vlodavsky I
J Clin Invest; 1997 Apr; 99(7):1565-75. PubMed ID: 9120000
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
[TBL] [Abstract][Full Text] [Related]
17. Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells.
Lehmann RJ; Jolly LA; Johnson BV; Lord MS; Kim HN; Saville JT; Fuller M; Byers S; Derrick-Roberts ALK
Mol Genet Metab Rep; 2021 Dec; 29():100811. PubMed ID: 34712574
[TBL] [Abstract][Full Text] [Related]
18. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
Rudd TR; Uniewicz KA; Ori A; Guimond SE; Skidmore MA; Gaudesi D; Xu R; Turnbull JE; Guerrini M; Torri G; Siligardi G; Wilkinson MC; Fernig DG; Yates EA
Org Biomol Chem; 2010 Dec; 8(23):5390-7. PubMed ID: 20865198
[TBL] [Abstract][Full Text] [Related]
19. 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.
Sugaya N; Habuchi H; Nagai N; Ashikari-Hada S; Kimata K
J Biol Chem; 2008 Apr; 283(16):10366-76. PubMed ID: 18281280
[TBL] [Abstract][Full Text] [Related]
20. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.
Kreuger J; Salmivirta M; Sturiale L; Giménez-Gallego G; Lindahl U
J Biol Chem; 2001 Aug; 276(33):30744-52. PubMed ID: 11406624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
